Ashley Moorman

Associate Scientist Inhalation R&d at Aurobindo Pharma USA, Inc.

Ashley Moorman has a diverse work experience spanning various industries and roles. Ashley is currently working as an Associate Scientist in Inhalation R&D at Aurobindo Pharma USA, Inc. Starting in January 2022. Prior to this, they worked at Tergus Pharma as a Quality Control Chemist from February 2021 to December 2021.

In 2020, Ashley worked at ENCO Pharmaceutical Development, Inc. (EPDI) as an Associate Scientist. Ashley'sresponsibilities included performing analysis of various materials, reviewing data trends, and supporting manufacturing with API in-process testing. Ashley also served as a Team Lead for the Stability Program, managing study protocols and sample stability time points.

Before entering the pharmaceutical industry, Ashley gained experience as a Swimming Pool Technician at Wake County in 2019. Ashley also served as a Graduate Teaching Assistant at Old Dominion University from August 2018 to May 2019. In this role, they encouraged learning, supervised laboratory sessions, and graded assignments.

Ashley began their career as a Teaching Assistant and Researcher at Liberty University from August 2017 to May 2018. Ashley then worked as a Pharmacy Technician at CVS/pharmacy from June 2015 to February 2016.

Overall, Ashley Moorman has developed a strong background in pharmaceuticals, quality control, research, and teaching throughout their professional journey.

Ashley Moorman's education history begins in 2010 when they attended Fuquay Varina High School for four years. After completing high school, Ashley attended Liberty University from 2014 to 2018 and obtained a Bachelor's degree in Chemistry. Following this, they pursued further studies at Old Dominion University Graduate School from 2018 to 2019 and earned a Master's degree in Marine Sciences. Lastly, from 2020 to 2021, Ashley attended the University of North Carolina Wilmington and completed a Master's degree in Chemistry.

Links

Timeline

  • Associate Scientist Inhalation R&d

    January, 2022 - present